FDA Approves EPINEPHRINE — Gland Pharma Limited
Gland Pharma Limited has received final approval from the FDA to manufacture and market generic epinephrine for intramuscular use. This addition to the regulatory portfolio positions the company to capture a significant share of the high-demand emergency injectable market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed